| Literature DB >> 24106649 |
Julián Benito-León1, Elan D Louis.
Abstract
BACKGROUND: The impact of scientific articles is proportional to the citations they have received. Our aim was to identify and analyze the top 100 cited articles on essential tremor (ET).Entities:
Keywords: Bibliometrics; citation analysis; essential tremor; top-cited
Year: 2013 PMID: 24106649 PMCID: PMC3782754 DOI: 10.7916/D8TM78VV
Source DB: PubMed Journal: Tremor Other Hyperkinet Mov (N Y) ISSN: 2160-8288
The 100 Top-Cited ET Articles
| Rank | Article | Number of Citations |
|---|---|---|
| 1 | Benamer HTS, Patterson J, Grosset DG, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. | 293 |
| 2 | Limousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. | 264 |
| 3 | Louis ED, Ottman R, Allen Hauser W. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. | 203 |
| 4 | Bain PG, Findley LJ, Thompson PD, et al. A study of hereditary essential tremor. | 202 |
| 5 | Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology 1991;41:234–238. | 164 |
| 6 | Gulcher JR, Jónsson P, Kong A, et al. Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. | 154 |
| 7 | Jenkins IH, Bain PG, Colebatch JG, et al. A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. | 153 |
| 8 | Benabid AL, Pollak P, Seigneuret E, Hoffmann D, Gay E, Perret J. Chronic VIM thalamic stimulation in Parkinson‘s disease, essential tremor and extra-pyramidal dyskinesias. | 136 |
| 9 | Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson’s disease tremor. | 133 |
| 10 | Louis ED. Essential tremor. | 132 |
| 11 | Louis ED, Faust PL, Vonsattel JP, et al. Neuropathological changes in essential tremor: 33 Cases compared with 21 controls. | 131 |
| 12 | Rajput AH, Offord, KP, Beard CM, Kurland LT. Essential tremor in Rochester, Minnesota: a 45-year study. | 130 |
| 13 | Koller WC, Busenbark K, Miner K, et al. The relationship of essential tremor to other movement disorders: report on 678 patients. | 128 |
| 14 | Deuschl G, Wenzelburger R, Löffler K, Raethjen J, Stolze H. Essential tremor and cerebellar dysfunction. Clinical and kinematic analysis of intention tremor. | 127 |
| 15 | Higgins JJ, Pho LT, Nee LE. A gene (ETM) for essential tremor maps to chromosome 2p22–p25. | 126 |
| 16 | Benito-León J, Bermejo-Pareja F, Morales J-M, Vega S, Molina J-A. Prevalence of essential tremor in three elderly populations of central Spain. | 118 |
| 17 | Dogu, O, Sevim S, Camdeviren H, et al. Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. | 112 |
| 18 | Stolze, H, Petersen, G, Raethjen J, Wenzelburger R, Deuschl G. The gait disorder of advanced essential tremor. | 110 |
| 19 | Gironell A, Kulisevsky J, Barbanoj M, López-Villegas D, Hernández G, Pascual-Sedano B. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. | 110 |
| 20 | Elble, RJ. Physiologic and essential tremor. | 109 |
| 21 | Zesiewicz TA, Elble RJ, Louis ED, et al. Practice parameter: therapies for essential tremor: report of the quality standards subcommittee of the American Academy of Neurology. | 105 |
| 22 | Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Brücke T. [123I]β-CIT and SPECT in essential tremor and Parkinson’s disease. | 100 |
| 23 | Bucher SF, Seelos KC, Dodel RC, Reiser M, Oertel WH. Activation mapping in essential tremor with functional magnetic resonance imaging. | 100 |
| 24 | Wills AJ, Jenkins IH, Thompson PD, Findley LJ, Brooks DJ. Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study. | 100 |
| 25 | Alesch F, Pinter MM, Helscher RJ, Fertl L, Benabid AL, Koos WT. Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson’s disease and essential tremor. | 99 |
| 26 | Deuschl G, Elble RJ. The pathophysiology of essential tremor. | 98 |
| 27 | Cohen O, Pullman S, Jurewicz E, Watner D, Louis ED. Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. | 97 |
| 28 | Bain P, Brin M, Deuschl G, et al. Criteria for the diagnosis of essential tremor. | 97 |
| 29 | Laesson T, Sjogren T. Essential tremor: a clinical and genetic population study. | 96 |
| 30 | Louis ED, Marder K, Cote L, et al. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in Northern Manhattan, NY. | 95 |
| 31 | Koller WC, Lyons KE, Wilkinson SB, Troster AI, Pahwa R. Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. | 94 |
| 32 | Elble RJ. Diagnostic criteria for essential tremor and differential diagnosis. Neurology 2000;54(11 SUPPL. 4):S2–S6. | 94 |
| 33 | Rautakorpi I, Takala J, Marttila RJ, Sievers K, Rinne UK. Essential tremor in a Finnish population. | 91 |
| 34 | Louis ED, Ottman R, Ford B, et al. The Washington Heights-Inwood Genetic Study of Essential tremor: methodologic issues in Essential-tremor research. | 88 |
| 35 | Colebatch JG, Findley LJ, Frackowiak RSJ, Marsden CD, Brooks DJ. Preliminary report: activation of the cerebellum in essential tremor. | 88 |
| 36 | Hariz MI, Shamsgovara P, Johansson F, Hariz G-M, Fodstad H. Tolerance and tremor rebound following long-term chronic thalamic stimulation for Parkinsonian and essential tremor. | 86 |
| 37 | Singer C, Sanchez-Ramos J, Weiner WJ. Gait abnormality in essential tremor. | 86 |
| 38 | Benito-León J, Louis ED. Essential tremor: emerging views of a common disorder. | 85 |
| 39 | Louis ED, Zheng W, Jurewicz EC, et al. Elevation of blood Β-carboline alkaloids in essential tremor. | 85 |
| 40 | Louis ED, Ottman R. How familial is familial tremor? The genetic epidemiology of essential tremor. | 85 |
| 41 | Lombardi WJ, Woolston DJ, Roberts JW, Gross RE. Cognitive deficits in patients with essential tremor. | 84 |
| 42 | Louis ED, Shungu DC, Chan S, Mao X, Jurewicz EC, Watner D. Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. | 83 |
| 43 | Louis ED, Barnes L, Albert SM, et al. Correlates of functional disability in essential tremor. | 83 |
| 44 | Leehey MA, Munhoz RP, Lang AE, et al. The fragile X premutation presenting as essential tremor. | 82 |
| 45 | Boecker H, Wills AJ, Ceballos-Baumann A, et al. The effect of ethanol on alcohol-responsive essential tremor: a position emission tomography study. | 81 |
| 46 | Benito-León J, Louis ED, Bermejo-Pareja F. Population-based case-control study of cognitive function in essential tremor | 80 |
| 47 | Pahwa R, Lyons K, Hubble JP, et al. Double-blind controlled trial of gabapentin in essential tremor. | 80 |
| 48 | Raethjen J, Lindemann M, Schmaljohann H, Wenzelburger R, Pfister G, Deuschl G. Multiple oscillators are causing parkinsonian and essential tremor. | 79 |
| 49 | Busenbark KL, Nash J, Nash S, Hubble JP, Koller WC. Is essential tremor benign? | 79 |
| 50 | Jankovic J. Essential tremor: a heterogeneous disorder. | 78 |
| 51 | Rajput, A, Robinson CA, Rajput AH. Essential tremor course and disability: a clinicopathologic study of 20 cases. | 77 |
| 52 | Louis ED, Ford B, Frucht S, Barnes LF, X-Tang M, Ottman R. Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. | 77 |
| 53 | Hellwig B, Häussler S, Schelter B, et al. Tremor-correlated cortical activity in essential tremor. | 77 |
| 54 | Hallett M, Dubinsky RM. Glucose metabolism in the brain of patients with essential tremor. | 76 |
| 55 | Benito-León J, Bermejo-Pareja, F, Louis ED. Incidence of essential tremor in three elderly populations of Central Spain. | 75 |
| 56 | Connor GS. A double-blind placebo-controlled trial of topiramate treatment for essential tremor. | 75 |
| 57 | Hubble JP, Busenbark KL, Wilkinson S, Penn RD, Lyons K, Koller WC. Deep brain stimulation for essential tremor. | 75 |
| 58 | Sydow O, Thobois S, Alesch F, Speelman JD. Multicentre European study of thalamic stimulation in essential tremor: a six year follow up. | 74 |
| 59 | Helmchen C, Hagenow A, Miesner J, et al. Eye movement abnormalities in essential tremor may indicate cerebellar dysfunction. | 74 |
| 60 | Ondo W, Hunter C, Vuong KD, Schwartz K, Jankovic J. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. | 73 |
| 61 | Jankovic, J. Essential tremor: clinical characteristics. | 73 |
| 62 | Dupuis MJM, Delwaide PJ, Boucquey D, Gonsette RE. Homolateral disappearance of essential tremor after cerebellar stroke. | 73 |
| 63 | Louis ED, Ford B, Lee H, Andrews H. Does a screening questionnaire for essential tremor agree with the physician‘s examination? | 72 |
| 64 | Salemi G, Savettieri G, Rocca WA, et al. Prevalence of essential tremor: a door-to-door survey in Terrasini, Sicily. | 72 |
| 65 | Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson’s disease. | 71 |
| 66 | Louis ED, Vonsattel JPG, Honig LS, Ross GW, Lyons KE, Pahwa R. Neuropathologic findings in essential tremor. | 71 |
| 67 | Deng H, Le W, Jankovic J. Genetics of essential tremor. | 70 |
| 68 | Higgins JJ, Loveless JM, Jankovic J, Patel PI. Evidence that a gene for essential tremor maps to chromosome 2p in four families. | 70 |
| 69 | Benito-León J, Louis ED, Bermejo-Pareja F. Elderly-onset essential tremor is associated with dementia. | 69 |
| 70 | Jeanneteau F, Funalot B, Jankovic J, et al. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. | 68 |
| 71 | Hubble JP, Busenbark KL, Pahwa R, Lyons K, Koller WC. Clinical expression of essential tremor: effects of gender and age. | 68 |
| 72 | Rajput AH, Rozdilsky B, Ang L, Rajput A. Clinicopathologic observations in essential tremor: report of six cases. | 68 |
| 73 | Louis ED. Essential tremor. | 67 |
| 74 | Koller WC, Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. | 67 |
| 75 | Geraghty JJ, Jankovic J, Zetusky WJ. Association between essential tremor and Parkinson’s disease. | 67 |
| 76 | Hornabrook RW, Nagurney JT. Essential tremor in Papua New Guinea. | 67 |
| 77 | Pahwa R, Lyons KL, Wilkinson SB, et al. Bilateral thalamic stimulation for the treatment of essential tremor. | 66 |
| 78 | Louis ED, Ford B, Lee H, Andrews H, Cameron G. Diagnostic criteria for essential tremor: a population perspective. | 66 |
| 79 | Kralic JE, Criswell HE, Osterman JL, et al. Genetic essential tremor in γ-aminobutyric acidA receptor α1 subunit knockout mice. | 65 |
| 80 | Tanner CM, Goldman SM, Lyons KE, et al. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. | 65 |
| 81 | Findley LJ, Koller WC. Essential tremor: a review. | 65 |
| 82 | Bermejo-Pareja F, Louis ED, Benito-León J. Risk of incident dementia in essential tremor: a population-based study. | 64 |
| 83 | Tröster AI, Woods SP, Fields JA, et al. Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology? | 64 |
| 84 | Pahwa R, Lyons KE, Wilkinson SB, et al. Comparison of thalamotomy to deep brain stimulation of the thalamus in essential tremor. | 64 |
| 85 | Hua SE, Lenz FA, Zirh TA, Reich SG, Dougherty PM. Thalamic neuronal activity correlated with essential tremor. | 64 |
| 86 | Louis ED, Honig LS, Vonsattel JPG, Maraganore DM, Borden S, Moskowitz CB. Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. | 63 |
| 87 | Koller WC, Royse VL. Efficacy of primidone in essential tremor. | 62 |
| 88 | Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. | 61 |
| 89 | Louis ED, Vonsattel JPG. The emerging neuropathology of essential tremor. | 61 |
| 90 | Findley LJ, Cleeves L, Calzetti S. Primidone in essential tremor of the hands and head: a double blind controlled clinical study. | 61 |
| 91 | Axelrad JE, Louis ED, Honig LS, et al. Reduced Purkinje cell number in essential tremor: a postmortem study. | 59 |
| 92 | Ondo WG, Jankovic J, Connor GS, et al. Topiramate in essential tremor: a double-blind, placebo-controlled trial | 59 |
| 93 | Gasparini M, Bonifati V, Fabrizio E, et al. Frontal lobe dysfunction in essential tremor: a preliminary study. | 59 |
| 94 | Benito-León J, Louis ED, Bermejo-Pareja F. Risk of incident Parkinson’s disease and parkinsonism in essential tremor: a population based study. | 58 |
| 95 | Findley LJ. Epidemiology and genetics of essential tremor. | 58 |
| 96 | Halliday DM, Conway BA, Farmer SF, Shahani U, Russell AJC, Rosenberg JR. Coherence between low-frequency activation of the motor cortex and tremor in patients with essential tremor. | 58 |
| 97 | Shill HA, Adler CH, Sabbagh MN, et al. Pathologic findings in prospectively ascertained essential tremor subjects. | 57 |
| 98 | Rajput AH, Rozdilsky B, Ang L, Rajput A. Significance of Parkinsonian manifestations in essential tremor. | 57 |
| 99 | Goldman MS, Ahlskog JE, Kelly PJ. The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. | 57 |
| 100 | Stefansson H, Steinberg S, Petursson H, et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. | 56 |
Journals that Published the 100 Top-Cited ET Articles
| Impact Factor | |||||
|---|---|---|---|---|---|
| Rank | Journal | 2011 | 5-Year Impact Factor | Number of Articles | Cited Half-Life |
| 1 | 8.312 | 7.634 | 31 | 8.7 | |
| 2 | 4.505 | 4.449 | 18 | 5.3 | |
| 3 | 11.089 | 10.644 | 7 | 9.0 | |
| 4 | 9.457 | 10.545 | 7 | 7.8 | |
| 5 | 7.584 | 6.928 | 7 | 8.9 | |
| 6 | 4.764 | 4.953 | 6 | >10.0 | |
| 7 | 38.278 | 33.797 | 3 | 8.9 | |
| 8 | 35.532 | 33.096 | 2 | 6.8 | |
| 9 | 1.520 | 1.839 | 2 | 9.8 | |
| 10 | 53.298 | 50.075 | 1 | 7.8 | |
| 11 | 23.462 | 20.598 | 1 | 3.8 | |
| 12 | 13.069 | 15.430 | 1 | 9.4 | |
| 13 | 9.681 | 10.472 | 1 | 7.8 | |
| 14 | 7.636 | 6.712 | 1 | 4.4 | |
| 15 | 4.220 | 4.299 | 1 | >10.0 | |
| 16 | 3.795 | 3.173 | 1 | 3.9 | |
| 17 | 3.692 | 3.239 | 1 | 4.5 | |
| 18 | 3.473 | 3.203 | 1 | 6.5 | |
| 19 | 2.965 | 3.088 | 1 | >10.0 | |
| 20 | 2.730 | 2.662 | 1 | 6.1 | |
| 21 | 2.469 | 2.347 | 1 | 9.8 | |
| 22 | 2.353 | 2.441 | 1 | 8.7 | |
| 23 | 2.305 | 2.817 | 1 | 6.3 | |
| 24 | 2.105 | 2.168 | 1 | 8.3 | |
| 25 | 1.849 | 1.913 | 1 | 9.4 | |
| 26 | 0.968 | 1.177 | 1 | 112 | |
FIGURE 1Publication Years for the 100 Top-Cited ET Articles.
Authors with Two or More Top-Cited ET Articles
| Rank | Author | Number of Citation Classics | Number of Articles | h-index | |
|---|---|---|---|---|---|
| As First Author | As Co-Author | ||||
| 1 | Louis ED | 27 | 17 | 10 | 48 |
| 2 | Koller WC | 15 | 4 | 11 | 58 |
| 3 | Jankovic J | 12 | 2 | 10 | 83 |
| 4 | Pahwa R | 11 | 3 | 8 | 46 |
| 5 | Lyons K | 11 | 0 | 11 | 21 |
| 6 | Findley LJ | 9 | 3 | 6 | 36 |
| 7 | Rajput AH | 8 | 5 | 4 | 40 |
| 8 | Rajput A | 8 | 2 | 6 | 37 |
| 9 | Benito-León J | 7 | 6 | 1 | 29 |
| 10 | Elble R | 6 | 2 | 4 | 19 |
| 11 | Deuschl G | 6 | 2 | 4 | 56 |
| 12 | Bermejo-Pareja F | 6 | 1 | 5 | 20 |
| 13 | Busenbark K | 5 | 1 | 4 | 16 |
| 14 | Ford B | 5 | 0 | 5 | 35 |
| 15 | Vonsattel JP | 5 | 0 | 5 | 34 |
| 16 | Ondo W | 4 | 3 | 1 | 20 |
| 17 | Tröster AI | 4 | 1 | 3 | 37 |
| 18 | Honig LS | 4 | 0 | 4 | 28 |
| 19 | Wilkinson S | 4 | 0 | 4 | 17 |
| 20 | Wenzelburger R | 4 | 0 | 4 | 16 |
| 21 | Thompson PD | 4 | 0 | 4 | 54 |
| 22 | Ottman R | 4 | 0 | 4 | 41 |
| 23 | Hubble JP | 4 | 0 | 4 | 27 |
| 24 | Brooks DJ | 4 | 0 | 4 | 87 |
| 25 | Bain PG | 3 | 2 | 1 | 25 |
| 26 | Raethjen J | 3 | 1 | 2 | 17 |
| 27 | Speelman JD | 3 | 0 | 3 | 32 |
| 28 | Ross GW | 3 | 0 | 3 | 39 |
| 29 | Pullman S | 3 | 0 | 3 | 12 |
| 30 | Marsden CD | 3 | 0 | 3 | 126 |
| 31 | Jurewicz EC | 3 | 0 | 3 | 10 |
| 32 | Hariz MI | 2 | 2 | 0 | 31 |
| 33 | Connor GS | 2 | 1 | 1 | 3 |
| 34 | Colebatch JG | 2 | 1 | 1 | 38 |
| 35 | Benabid AL | 2 | 1 | 1 | 60 |
| 36 | Stolze H | 2 | 1 | 1 | 19 |
| 37 | Deng H | 2 | 1 | 1 | 22 |
| 38 | Wills AJ | 2 | 1 | 1 | 15 |
| 39 | Alesch F | 2 | 1 | 1 | 18 |
| 40 | Hauser W | 2 | 0 | 2 | 23 |
| 41 | Weiner WJ | 2 | 0 | 2 | 45 |
| 42 | Tang MX | 2 | 0 | 2 | 50 |
| 43 | Stefansson K | 2 | 0 | 2 | 24 |
| 44 | Schwartz K | 2 | 0 | 2 | 19 |
| 45 | Rozdilsky B | 2 | 0 | 2 | 29 |
| 46 | Robinson CA | 2 | 0 | 2 | 8 |
| 47 | Overman J | 2 | 0 | 2 | 10 |
| 48 | Oertel WH | 2 | 0 | 2 | 55 |
| 49 | Nash J | 2 | 0 | 2 | 14 |
| 50 | Moskowitz CB | 2 | 0 | 2 | 14 |
| 51 | Lee H | 2 | 0 | 2 | 31 |
| 52 | Kong A | 2 | 0 | 2 | 6 |
| 53 | Jenkins IH | 2 | 0 | 2 | 16 |
| 54 | Jakobsson F | 2 | 0 | 2 | 6 |
| 55 | Higgins JJ | 2 | 0 | 2 | 18 |
| 56 | Benedickz J | 2 | 0 | 2 | 1 |
| 57 | Frackowiak RSJ | 2 | 0 | 2 | 76 |
| 58 | Faust PL | 2 | 0 | 2 | 12 |
| 59 | Cote L | 2 | 0 | 2 | 33 |
| 60 | Borden S | 2 | 0 | 2 | 4 |
| 61 | Barnes LF | 2 | 0 | 2 | 7 |
| 62 | Andrews H | 2 | 0 | 2 | 26 |
Country of Origin of the 100 Top-Cited ET Articles
| Rank | Country of Origin | Number of Articles |
|---|---|---|
| 1 | USA | 54 |
| 2 | United Kingdom | 11 |
| 3 | Spain | 8 |
| 4 | Germany | 7 |
| 5 | Canada | 4 |
| 6 | France | 3 |
| 7 | Sweden | 3 |
| 8 | Austria | 2 |
| 9 | Italy | 2 |
| 10 | Iceland | 2 |
| 11 | Finland | 1 |
| 12 | Belgium | 1 |
| 13 | Turkey | 1 |
| 14 | Papua New Guinea | 1 |
Institution of Origin of Authors with Two or More Top-Cited ET Articles
| Rank | Country of Origin | Number of Articles |
|---|---|---|
| 1 | Columbia University, New York, New York, USA | 19 |
| 2 | University of Kansas Medical Center, Kansas City, Kansas, USA | 18 |
| 3 | Baylor College of Medicine, Houston, Texas, USA | 9 |
| 4 | Móstoles University Hospital, Móstoles, Madrid, Spain | 6 |
| 5 | University of Saskatchewan, Saskatoon, Saskatchewan, Canada | 5 |
| 6 | Hammersmith Hospital, London, United Kingdom | 4 |
| 7 | Christian-Albrechts-University of Kiel, Kiel, Germany | 4 |
| 8 | Oldchurch Hospital, Romford, United Kingdom | 3 |
| 9 | Institute of Neurology, London, United Kingdom | 2 |
| 10 | deCODE Genetics, Reykjavik, Iceland | 2 |
| 11 | Southern Illinois University School of Medicine, Springfield, Illinois, USA | 2 |
| 12 | University of Vienna, Austria | 2 |
| 13 | National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA | 2 |
Study Design of the Clinical Studies
| Study Design | Number of Articles |
|---|---|
| Randomized, controlled trial, open-label trial | 6 |
| Cohort study | 4 |
| Case-control study | 24 |
| Cross-sectional study | 10 |
| Case series | 34 |
| Case report | 2 |
| 1 | |
| 18 | |
| 1 |
Level of Evidence of the Clinical Studies
| Levels of Evidence | Number of Articles |
|---|---|
| 1 | |
| 79 | |
| 18 |